Amgen Inc (BSP:AMGN34)
R$ 58.14 0 (0%) Market Cap: 881.03 Bil Enterprise Value: 1.20 Til PE Ratio: 34.15 PB Ratio: 19.04 GF Score: 86/100

Q3 2022 Amgen Inc Earnings Call Transcript

Nov 03, 2022 / 08:30PM GMT
Release Date Price: R$48.66 (-2.27%)
Operator

My name is Jason, and I will be your conference facilitator today for Amgen's Third Quarter 2022 Financial Results Conference Call. (Operator Instructions)

I would now like to introduce Arvind Sood, Vice President of Investor Relations. Mr. Sood, you may now begin.

Arvind Sood
Amgen Inc. - VP of IR

Okay. Thank you, Jason. Good afternoon, everybody, and welcome to our Q3 call. So we continued with our execution during the quarter with a focus on driving volume growth for our key products and advancing our innovative pipeline.

Leading the discussion today will be our Chairman and CEO, Bob Bradway. We have posted some slides for your reference and my customary reminder that we'll be making some forward-looking statements and use non-GAAP financial measures to describe our performance.

So with that, I would like to turn the call over to Bob.

Robert A. Bradway
Amgen Inc. - Chairman, CEO & President

Okay. Thank you, all of you, for joining our call. In the face of both macroeconomic and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot